SKNV Launches Kefunova™, a Custom Formulated 5-FU Prescription Medication
Hand-out
Press Releases
SKNV  
April 30, 2025

SKNV Launches Kefunova™, a Custom Formulated 5-FU Prescription Medication

A Direct Response to Provider Demand for Advanced Actinic Keratosis Therapy and Superficial Basal Cell Carcinoma

logo salamanca press

Salamanca Press

Local & Social